Skip to content
CancerIndex

Loading clinical trial…

NCT05676450 — Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas · CancerIndex